It is trading at $41.55 marginally over $39.26, the 50 day moving average and barely above the 200 day moving average of $38.49. The 50 day moving average was up $2.29 or +5.83% and the 200 day average was up $3.06. Trading volume for Black Knight Financial Services was 194K by the end of trading on Thursday. Shares saw a steep increase in trading volume of 69.90% over the normal average daily volume.
Here is the rundown on market activity for Black Knight Financial Services (NYSE:BKFS). Chief Operating Officer Anthony Orefice let go of 30,000 shares at an average price of $38.50 on May 19th. Orefice now owns $4,665,161 of stock as reported to the SEC. Thomas J. Sanzone, CEO disclosed the sale of 30,000 shares of BKFS stock. The shares were purchased at an average price of $39.17. The CEO now owns $15,819,745 of the stock per the Form 4 SEC filing.
Thomas J. Sanzone, CEO reported the sale of 30,000 shares. The shares were sold on April 17th for an average price of $38.45. Sanzone now owns $16,682,455 of the stock according to the SEC filing.
Here are a few other firms who have also updated their positions. Hollencrest Securities LLC cut its position by selling 3,756 shares a decrease of 14.4% in the quarter. Hollencrest Securities LLC controls 22,244 shares worth $911,000. The value of the position overall is down by 8.5%. Symphony Asset Management LLC reduced its investment by shedding 13,246 shares a decrease of 33.8% from 03/31/2016 to 06/30/2016. Symphony Asset Management LLC currently owns 25,991 shares with a value of $977,000. The total value of its holdings decreased 19.8%.
As of the end of the quarter Morgan Stanley had sold a total of 19 shares trimming its holdings by 9.3%. The value of the investment in BKFS went from $8,000 to $7,000 a change of $1,000 quarter over quarter. Tower Research Capital LLC (trc) augmented its ownership by buying 1,817 shares an increase of 310.6%. Tower Research Capital LLC (trc) now controls 2,402 shares valued at $92,000. The value of the position overall is up by 318.2%.
On September 19 the company was upgraded from “” to “Outperform” with a current price target of $46.00 by analysts at Keefe Bruyette & Woods. On July 21 the company was changed to a “Sell” in a report from Monness Crespi Hardt which is down from the previous “Neutral” rating.
February 16 investment analysts at Keefe Bruyette & Woods made no change to the stock rating of “Market Perform” but moved down the price target from $36.00 to $33.00. On February 12 Barclays held the stock rating at “Overweight” and lowered the price target to $35.00 from $39.00.
On January 13 the stock rating was upgraded to “Buy” from “Neutral” in a report issued by Bank of America. On November 12 the company was downgraded to “Neutral” from “Buy” by Monness Crespi Hardt.
The company is trading up by 1.47% since yesterday’s close of $40.95. The most current P/E ratio is 60.22 and the market cap of the company is 2.82B. As of the last earnings report the EPS was $0.69 and is estimated to be $1.36 for the current year with 67,904,000 shares currently outstanding. Analysts expect next quarter’s EPS to be $0.37 and the next full year EPS is projected to be $1.60.
Black Knight Financial Services, Inc., launched on October 27, 2014, is a holding company. The Company, through its subsidiaries, provides integrated technology, workflow automation, and data and analytics to the mortgage and real estate industries. The Business’s segments include Technology, and Data and Analytics. The Business’s Technology segment offers software and hosting solutions that support loan servicing, loan origination and settlement services. Its Data and Analytics segment offers data and analytics solutions to the mortgage, real estate and capital markets industries. These solutions include property ownership data, lien data, servicing data, automated valuation models, collateral risk scores, prepayment and default models, lead generation and other data solutions. Its subsidiaries include Black Knight InfoServ, LLC and Black Knight Financial Services, LLC..Advertisement